53 research outputs found

    Integration of a specialist into the international space: linguistic training and cross cultural interaction

    Get PDF
    The article considers the possibilities of international internships for medical students and doctors. The problems of insufficient linguistic training of health care manpower for representing Russian Federation at the international level are discussed. Ways to work out these issues are suggested

    Π›ΡŽΠ΄ΠΈ с ΠΎΠ³Ρ€Π°Π½ΠΈΡ‡Π΅Π½Π½Ρ‹ΠΌΠΈ возмоТностями: адаптация ΠΊ ΡΠΎΡ†ΠΈΠ°Π»ΡŒΠ½ΠΎΠΉ срСдС

    Full text link
    The article discusses the problems that people with disabilities face every day. Loneliness, misunderstanding, detachment, lack of money make such people unhappy. The article proposes the solution of many social issues, such as finding a job, government support, changing the attitude of ordinary people to people with disabilities, the formation of an inclusive society, the fight against discrimination, leisure activities. There are also examples of successful implementation of various projects and holding large-scale events in Yekaterinburg, such as Β«Accessible YekaterinburgΒ», the First World Congress for People with Disabilities in 2017, Β«Lessons of GoodnessΒ» in schools. This article reveals the problem of social adaptation of persons with disabilities, not only as a state, but also a public. It proves that only by joint efforts of the state and common citizens is it possible to make significant changes to the problem under discussion. Also, in this article there are examples of the real value of the equipment necessary for the daily life of people with disabilities. Today, despite the large number of changes in the social sphere, there are a large number of unresolved issues in improving the quality of life of people with disabilities.Π’ ΡΡ‚Π°Ρ‚ΡŒΠ΅ рассмотрСны ΠΏΡ€ΠΎΠ±Π»Π΅ΠΌΡ‹, с ΠΊΠΎΡ‚ΠΎΡ€Ρ‹ΠΌΠΈ ΠΈΠ½Π²Π°Π»ΠΈΠ΄Ρ‹ ΡΡ‚Π°Π»ΠΊΠΈΠ²Π°ΡŽΡ‚ΡΡ ΠΊΠ°ΠΆΠ΄Ρ‹ΠΉ дСнь. ΠžΠ΄ΠΈΠ½ΠΎΡ‡Π΅ΡΡ‚Π²ΠΎ, Π½Π΅ΠΏΠΎΠ½ΠΈΠΌΠ°Π½ΠΈΠ΅, ΠΎΡ‚ΡΡ‚Ρ€Π°Π½Π΅Π½Π½ΠΎΡΡ‚ΡŒ, Π½Π΅Ρ…Π²Π°Ρ‚ΠΊΠ° Π΄Π΅Π½Π΅Π³ Π΄Π΅Π»Π°ΡŽΡ‚ Ρ‚Π°ΠΊΠΈΡ… людСй нСсчастливыми. Π’ ΡΡ‚Π°Ρ‚ΡŒΠ΅ прСдлагаСтся Ρ€Π΅ΡˆΠ΅Π½ΠΈΠ΅ ΠΌΠ½ΠΎΠ³ΠΈΡ… ΡΠΎΡ†ΠΈΠ°Π»ΡŒΠ½Ρ‹Ρ… вопросов, Ρ‚Π°ΠΊΠΈΡ… ΠΊΠ°ΠΊ устройство Π½Π° Ρ€Π°Π±ΠΎΡ‚Ρƒ, государствСнная ΠΏΠΎΠ΄Π΄Π΅Ρ€ΠΆΠΊΠ°, ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΠΎΡ‚Π½ΠΎΡˆΠ΅Π½ΠΈΡ ΠΎΠ±Ρ‹Ρ‡Π½Ρ‹Ρ… людСй ΠΊ людям с ΠΈΠ½Π²Π°Π»ΠΈΠ΄Π½ΠΎΡΡ‚ΡŒΡŽ, Ρ„ΠΎΡ€ΠΌΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠ΅ инклюзивного общСства, Π±ΠΎΡ€ΡŒΠ±Π° с дискриминациСй, организация досуга. Π’Π°ΠΊΠΆΠ΅ ΠΈΠΌΠ΅ΡŽΡ‚ΡΡ ΠΏΡ€ΠΈΠΌΠ΅Ρ€Ρ‹ ΡƒΡΠΏΠ΅ΡˆΠ½ΠΎΠ³ΠΎ внСдрСния Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹Ρ… ΠΏΡ€ΠΎΠ΅ΠΊΡ‚ΠΎΠ² ΠΈ ΠΏΡ€ΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅ ΠΌΠ°ΡΡˆΡ‚Π°Π±Π½Ρ‹Ρ… мСроприятий Π² Π•ΠΊΠ°Ρ‚Π΅Ρ€ΠΈΠ½Π±ΡƒΡ€Π³Π΅, Ρ‚Π°ΠΊΠΈΡ… ΠΊΠ°ΠΊ «Доступный Π•ΠΊΠ°Ρ‚Π΅Ρ€ΠΈΠ½Π±ΡƒΡ€Π³Β», ΠŸΠ΅Ρ€Π²Ρ‹ΠΉ ВсСмирный конгрСсс для людСй с ΠΈΠ½Π²Π°Π»ΠΈΠ΄Π½ΠΎΡΡ‚ΡŒΡŽ Π² 2017 Π³ΠΎΠ΄Ρƒ, Β«Π£Ρ€ΠΎΠΊΠΈ Π΄ΠΎΠ±Ρ€Π°Β» Π² ΡˆΠΊΠΎΠ»Π°Ρ…. Данная ΡΡ‚Π°Ρ‚ΡŒΡ раскрываСт ΠΏΡ€ΠΎΠ±Π»Π΅ΠΌΡƒ ΡΠΎΡ†ΠΈΠ°Π»ΡŒΠ½ΠΎΠΉ Π°Π΄Π°ΠΏΡ‚Π°Ρ†ΠΈΠΈ ΠΈΠ½Π²Π°Π»ΠΈΠ΄ΠΎΠ² Π½Π΅ Ρ‚ΠΎΠ»ΡŒΠΊΠΎ ΠΊΠ°ΠΊ Π³ΠΎΡΡƒΠ΄Π°Ρ€ΡΡ‚Π²Π΅Π½Π½ΡƒΡŽ, Π½ΠΎ ΠΈ ΠΎΠ±Ρ‰Π΅ΡΡ‚Π²Π΅Π½Π½ΡƒΡŽ. Она Π΄ΠΎΠΊΠ°Π·Ρ‹Π²Π°Π΅Ρ‚, Ρ‡Ρ‚ΠΎ Ρ‚ΠΎΠ»ΡŒΠΊΠΎ совмСстными усилиями государства ΠΈ ΠΎΠ±Ρ‹Ρ‡Π½Ρ‹Ρ… ΠΆΠΈΡ‚Π΅Π»Π΅ΠΉ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎ внСсти сущСствСнныС измСнСния Π² ΠΎΠ±ΡΡƒΠΆΠ΄Π°Π΅ΠΌΡƒΡŽ ΠΏΡ€ΠΎΠ±Π»Π΅ΠΌΡƒ. Π’Π°ΠΊΠΆΠ΅ Π² этой ΡΡ‚Π°Ρ‚ΡŒΠ΅ ΠΈΠΌΠ΅ΡŽΡ‚ΡΡ ΠΏΡ€ΠΈΠΌΠ΅Ρ€Ρ‹ Ρ€Π΅Π°Π»ΡŒΠ½ΠΎΠΉ стоимости инвСнтаря, Π½Π΅ΠΎΠ±Ρ…ΠΎΠ΄ΠΈΠΌΠΎΠ³ΠΎ для повсСднСвной ΠΆΠΈΠ·Π½ΠΈ людСй с ΠΈΠ½Π²Π°Π»ΠΈΠ΄Π½ΠΎΡΡ‚ΡŒΡŽ. На сСгодняшний дСнь, нСсмотря Π½Π° большоС число ΠΏΠ΅Ρ€Π΅ΠΌΠ΅Π½ Π² ΡΠΎΡ†ΠΈΠ°Π»ΡŒΠ½ΠΎΠΉ сфСрС, имССтся большоС количСство Π½Π΅Ρ€Π΅ΡˆΠ΅Π½Π½Ρ‹Ρ… вопросов Π² ΡƒΠ»ΡƒΡ‡ΡˆΠ΅Π½ΠΈΠΈ качСства ΠΆΠΈΠ·Π½ΠΈ людСй с ΠΈΠ½Π²Π°Π»ΠΈΠ΄Π½ΠΎΡΡ‚ΡŒΡŽ

    C9orf16 (BBLN) gene, encoding a member of Hero proteins, is a novel marker in ischemic stroke risk

    Get PDF
    To investigate an association between a single nucleotide polymorphism rs2900262 in the gene encoding C9orf16 and predisposition to I

    Follow-up stadies patients undergoing legionnaires’ disease during epidemic outbreak of legionellosis in the Sverdlovsk region

    Get PDF
    For the first time described the sustainability of clinical symptoms, laboratory, ECG and radiographic changes, assess the quality of life due to health within the follow-up study of non-small but well defined group of 46 patients who suffered legionnaires' disease (LD) during epidemic outbreaks of legionellosis in the Sverdlovsk Oblast. The most prevalent and persistent clinical symptoms at 12 months had a cough and increased blood pressure. According to the results of studies conducted in patients undergoing LD, 1 year after hospital discharge, it should be noted: the preservation of normative values of red blood cells and hemoglobin level, normalizing the number of leukocytes, neutrophils, lymphocytes, and erythrocyte sedimentation rate, absence of "fresh’ electrocardiography and radiographic changes, the transitory nature of the relative reliability of thrombocytosis and the syndrome of hepatocyte cytolysis. Quality of life was significantly disrupted in three of the eight indicators, as assessed by SF-36 form, and is due to reduced levels of physical activity in male patients, the increase in subjec-tive pain, decline in social relationships and social activity, with a one-time increase the viability and reduced anxiety and restlessness. The results of our study suggest that the medical work-ship should be aware of possible manifestations of persistent symptoms, at breach of the quality of life due to health, especially in the situation of the epidemic, as patients will turn to them for help. Awareness of these issues will help provide more quality in the power of such patients. Thus, the legionnaires' disease can have a negative impact on with-standing health most patients for at least 12 months after discharge from the hospital.Π’ΠΏΠ΅Ρ€Π²Ρ‹Π΅ описана ΡƒΡΡ‚ΠΎΠΉΡ‡ΠΈΠ²ΠΎΡΡ‚ΡŒ клиничСских симптомов, Π»Π°Π±ΠΎΡ€Π°Ρ‚ΠΎΡ€Π½Ρ‹Ρ…, элСктрокардиографичСских ΠΈ рСнтгСнологичСских ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΉ, Π΄Π°Π½Π° ΠΎΡ†Π΅Π½ΠΊΠ° качСства ΠΆΠΈΠ·Π½ΠΈ, обусловлСнного состояниСм Π·Π΄ΠΎΡ€ΠΎΠ²ΡŒΡ Π² Ρ€Π°ΠΌΠΊΠ°Ρ… катамнСстичСского исслСдования нСбольшой, Π½ΠΎ Ρ‡Π΅Ρ‚ΠΊΠΎ ΠΎΠΏΡ€Π΅Π΄Π΅Π»Π΅Π½Π½ΠΎΠΉ Π³Ρ€ΡƒΠΏΠΏΡ‹ ΠΈΠ· 46 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ², ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Π΅ пСрСнСсли Π»Π΅Π³ΠΈΠΎΠ½Π΅Π»Π»Π΅Π·Π½ΡƒΡŽ пнСвмонию (ЯП) Π²ΠΎ врСмя эпидСмичСской Π²ΡΠΏΡ‹ΡˆΠΊΠΈ Π»Π΅Π³ΠΈΠΎΠ½Π΅Π»Π»Π΅Π·Π° Π² БвСрдловской области. НаиболСС распространСнными ΠΈ устойчивыми клиничСскими симптомами Ρ‡Π΅Ρ€Π΅Π· 12 мСсяцСв Π±Ρ‹Π»ΠΈ кашСль ΠΈ ΠΏΠΎΠ²Ρ‹ΡˆΠ΅Π½ΠΈΠ΅ уровня Π°Ρ€Ρ‚Π΅Ρ€ΠΈΠ°Π»ΡŒΠ½ΠΎΠ³ΠΎ давлСния. По Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Π°ΠΌ исслСдований, ΠΏΡ€ΠΎΠ²Π΅Π΄Π΅Π½Π½Ρ‹Ρ… Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ², ΠΏΠ΅Ρ€Π΅Π½Π΅ΡΡˆΠΈΡ… ЯП, Ρ‡Π΅Ρ€Π΅Π· 1 Π³ΠΎΠ΄ послС выписки ΠΈΠ· стационара, слСдуСт ΠΎΡ‚ΠΌΠ΅Ρ‚ΠΈΡ‚ΡŒ: сохранСниС Π½ΠΎΡ€ΠΌΠ°Ρ‚ΠΈΠ²Π½Ρ‹Ρ… Π·Π½Π°Ρ‡Π΅Π½ΠΈΠΉ числа эритроцитов ΠΈ уровня Π³Π΅ΠΌΠΎΠ³Π»ΠΎΠ±ΠΈΠ½Π°; Π½ΠΎΡ€ΠΌΠ°Π»ΠΈΠ·Π°Ρ†ΠΈΡŽ количСства Π»Π΅ΠΉΠΊΠΎΡ†ΠΈΡ‚ΠΎΠ², Π½Π΅ΠΉΡ‚Ρ€ΠΎΡ„ΠΈΠ»ΠΎΠ², Π»ΠΈΠΌΡ„ΠΎΡ†ΠΈΡ‚ΠΎΠ² ΠΈ БОЭ; отсутствиС «свСТих» элСктрокардиографичСских ΠΈ рСнтгСнологичСских ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΉ; Π΄ΠΎΡΡ‚ΠΎΠ²Π΅Ρ€Π½ΠΎΡΡ‚ΡŒ прСходящСго Ρ…Π°Ρ€Π°ΠΊΡ‚Π΅Ρ€Π° ΠΎΡ‚Π½ΠΎΡΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠ³ΠΎ Ρ‚Ρ€ΠΎΠΌΠ±ΠΎΡ†ΠΈΡ‚ΠΎΠ·Π° ΠΈ синдрома Ρ†ΠΈΡ‚ΠΎΠ»ΠΈΠ·Π° Π³Π΅ΠΏΠ°Ρ‚ΠΎΡ†ΠΈΡ‚ΠΎΠ². ΠšΠ°Ρ‡Π΅ΡΡ‚Π²ΠΎ ΠΆΠΈΠ·Π½ΠΈ Π±Ρ‹Π»ΠΎ Π² Π·Π½Π°Ρ‡ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠΉ стСпСни Π½Π°Ρ€ΡƒΡˆΠ΅Π½ΠΎ ΠΏΠΎ Ρ‚Ρ€Π΅ΠΌ показатСлям ΠΈΠ· восьми, ΠΎΡ†Π΅Π½ΠΈΠ²Π°Π΅ΠΌΡ‹ΠΌ ΠΏΠΎ Ρ„ΠΎΡ€ΠΌΠ΅ SF-36, ΠΈ обусловлСно сниТСниСм уровня физичСской активности Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² ΠΌΡƒΠΆΡ‡ΠΈΠ½; ΡƒΠ²Π΅Π»ΠΈΡ‡Π΅Π½ΠΈΠ΅ΠΌ объСма ΡΡƒΠ±ΡŠΠ΅ΠΊΡ‚ΠΈΠ²Π½Ρ‹Ρ… Π±ΠΎΠ»Π΅Π²Ρ‹Ρ… ΠΎΡ‰ΡƒΡ‰Π΅Π½ΠΈΠΉ, ΡƒΠΌΠ΅Π½ΡŒΡˆΠ΅Π½ΠΈΠ΅ΠΌ объСма ΡΠΎΡ†ΠΈΠ°Π»ΡŒΠ½Ρ‹Ρ… связСй ΠΈ ΡΠΎΡ†ΠΈΠ°Π»ΡŒΠ½ΠΎΠΉ активности, с ΠΎΠ΄Π½ΠΎΠ²Ρ€Π΅ΠΌΠ΅Π½Π½Ρ‹ΠΌ ΡƒΠ²Π΅Π»ΠΈΡ‡Π΅Π½ΠΈΠ΅ΠΌ ТизнСспособности ΠΈ сниТСниСм трСвоТности ΠΈ бСспокойства. Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹ нашСго исслСдования ΡΠ²ΠΈΠ΄Π΅Ρ‚Π΅Π»ΡŒΡΡ‚Π²ΡƒΡŽΡ‚ ΠΎ Ρ‚ΠΎΠΌ, Ρ‡Ρ‚ΠΎ мСдицинскиС Ρ€Π°Π±ΠΎΡ‚Π½ΠΈΠΊΠΈ Π΄ΠΎΠ»ΠΆΠ½Ρ‹ Π±Ρ‹Ρ‚ΡŒ освСдомлСны ΠΎ возмоТности проявлСния устойчивых симптомов, Π½Π°Ρ€ΡƒΡˆΠ΅Π½ΠΈΡ качСства ΠΆΠΈΠ·Π½ΠΈ, обусловлСнного состояниСм Π·Π΄ΠΎΡ€ΠΎΠ²ΡŒΡ, особСнно Π² ситуации эпидСмии, ΠΏΠΎΡΠΊΠΎΠ»ΡŒΠΊΡƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚Ρ‹ Π±ΡƒΠ΄ΡƒΡ‚ ΠΎΠ±Ρ€Π°Ρ‰Π°Ρ‚ΡŒΡΡ ΠΊ Π½ΠΈΠΌ Π·Π° ΠΏΠΎΠΌΠΎΡ‰ΡŒΡŽ с ΠΏΠΎΠ΄ΠΎΠ±Π½Ρ‹ΠΌΠΈ ΠΆΠ°Π»ΠΎΠ±Π°ΠΌΠΈ. ΠžΡΠ²Π΅Π΄ΠΎΠΌΠ»Π΅Π½Π½ΠΎΡΡ‚ΡŒ Π² этих вопросах ΠΏΠΎΠΌΠΎΠΆΠ΅Ρ‚ ΠΎΠΊΠ°Π·Π°Ρ‚ΡŒ Π±ΠΎΠ»Π΅Π΅ ΠΊΠ°Ρ‡Π΅ΡΡ‚Π²Π΅Π½Π½ΡƒΡŽ ΠΏΠΎΠΌΠΎΡ‰ΡŒ Ρ‚Π°ΠΊΠΈΠΌ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚Π°ΠΌ. Π’Π°ΠΊΠΈΠΌ ΠΎΠ±Ρ€Π°Π·ΠΎΠΌ, болСзнь Π»Π΅Π³ΠΈΠΎΠ½Π΅Ρ€ΠΎΠ² ΠΌΠΎΠΆΠ΅Ρ‚ ΠΎΠΊΠ°Π·Ρ‹Π²Π°Ρ‚ΡŒ Π½Π΅Π³Π°Ρ‚ΠΈΠ²Π½ΠΎΠ΅ влияниС Π½Π° состояниС Π·Π΄ΠΎΡ€ΠΎΠ²ΡŒΡ большой части ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² Π½Π° протяТСнии, ΠΏΠΎ мСньшСй ΠΌΠ΅Ρ€Π΅, 12 мСсяцСв послС выписки ΠΈΠ· стационара

    Modern ideas about the ferrokinetics features in the human body

    Get PDF
    This article is devoted to the problem of absorption of Fe+2 and Fe+3 ions that provide vital functions of the body. The article considers various ways of iron absorption carried out by numerous protein transporters, and notes their specialization in the assimilation of a certain ion.Данная ΡΡ‚Π°Ρ‚ΡŒΡ посвящСна ΠΏΡ€ΠΎΠ±Π»Π΅ΠΌΠ΅ всасывания ΠΈΠΎΠ½ΠΎΠ² Fe+2 ΠΈ Fe+3, ΠΎΠ±Π΅ΡΠΏΠ΅Ρ‡ΠΈΠ²Π°ΡŽΡ‰ΠΈΡ… ΠΆΠΈΠ·Π½Π΅Π½Π½ΠΎ Π½Π΅ΠΎΠ±Ρ…ΠΎΠ΄ΠΈΠΌΡ‹Π΅ Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΈ ΠΎΡ€Π³Π°Π½ΠΈΠ·ΠΌΠ°. Π’ ΡΡ‚Π°Ρ‚ΡŒΠ΅ рассмотрСны Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹Π΅ ΠΏΡƒΡ‚ΠΈ абсорбции ΠΆΠ΅Π»Π΅Π·Π°, осущСствляСмыС многочислСнными Π±Π΅Π»ΠΊΠ°ΠΌΠΈ транспортСрами, ΠΈ ΠΎΡ‚ΠΌΠ΅Ρ‡Π΅Π½Π° ΠΈΡ… спСциализация Π½Π° усвоСниС ΠΎΠΏΡ€Π΅Π΄Π΅Π»Π΅Π½Π½ΠΎΠ³ΠΎ ΠΈΠΎΠ½

    ΠŸΡ€ΠΎΠ³Π½ΠΎΡΡ‚ΠΈΡ‡Π΅ΡΠΊΠΎΠ΅ Π·Π½Π°Ρ‡Π΅Π½ΠΈΠ΅ матриксных ΠΌΠ΅Ρ‚Π°Π»Π»ΠΎΠΏΡ€ΠΎΡ‚Π΅ΠΈΠ½Π°Π· Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с Π°Π½Ρ‚Ρ€Π°Ρ†ΠΈΠΊΠ»ΠΈΠ½ΠΈΠ½Π΄ΡƒΡ†ΠΈΡ€ΠΎΠ²Π°Π½Π½ΠΎΠΉ сСрдСчной Π½Π΅Π΄ΠΎΡΡ‚Π°Ρ‚ΠΎΡ‡Π½ΠΎΡΡ‚ΡŒΡŽ

    Get PDF
    Highlights. Elevated levels of matrix metalloproteinases 2 and 9 are associated with the initiation and severity of CHF developed after breast cancer therapy with anthracyclines, which may contribute to cardiac remodeling and the progression of systolic dysfunction. Concentrations of matrix metalloproteinases-2 and -9 in blood serum serve as predictors of the unfavorable course of anthracycline-induced heart failure.Aim. To assess the role of matrix metalloproteinases-2 (MMP-2) and 9 (MMP-9) in the development and course of anthracycline-induced chronic heart failure (CHF) during 24 months of observation.Methods. The study included 114 women 12 months after completion of chemotherapy (CT) for breast cancer and developed CHF. The control group (n = 70) consisted of women (mean age 45.0 [42.0; 50.0] years old) who received doxorubicin as part of chemotherapy, but they did not develop CHF 12 months after completion of chemotherapy. The levels of biomarkers (MMP-2, MMP-9, NT-proBNP) in blood serum were determined using a sandwich immunoassay.Results. Patients with CHF had signs of cardiac remodeling and higher values of NT-proBNP, MMP-2 and MMP-9 (p<0.001) than women from the control group. After 24 months of observation, all patients with CHF were divided into 2 groups: group 1 – women with an unfavorable course of CHF (n = 54), group 2 – women with favorable course of pathology (n = 60). Criteria for the unfavorable course of CHF: the emergence of new or worsening of existing symptoms/signs of heart failure; and/or hospitalization due to HF decompensation; decrease in left ventricular ejection fraction by more than 10%; or an increase in the functional class of CHF by 1 or more. Baseline echocardiographic parameters and NT-proBNP values did not differ in groups 1 and 2. Levels of MMP-2 were higher by 8% (p = 0.017) and MMP-9 by 18.4% (p<0.001) in group 1. In 1 group the level of MMP-2 decreased after 24 months of observation. In group 2 the level of MMP-2 increased by the end of the observation period. MMP-2 levels β‰₯388.2 pg/ml (sensitivity 46%, specificity 80%; AUC = 0.64; p = 0.013) and MMP-9 β‰₯21.3 pg/ml (sensitivity 86%, specificity 84.4%; AUC = 0.9; p<0.001) were determined as predictors of an unfavorable course of CHF.Conclusion. Remodeling of the extracellular matrix may play an important role in the pathogenesis of CHF initiated by drugs of the anthracycline class. Elevated levels of MMP-2 and MMP-9 in the blood serum are associated with an unfavorable course of anthracycline-induced CHF and can be recommended when assessing the risk of an unfavorable course of pathology.ΠžΡΠ½ΠΎΠ²Π½Ρ‹Π΅ полоТСния. ΠŸΠΎΠ²Ρ‹ΡˆΠ΅Π½Π½Ρ‹Π΅ ΡƒΡ€ΠΎΠ²Π½ΠΈ матриксных ΠΌΠ΅Ρ‚Π°Π»Π»ΠΎΠΏΡ€ΠΎΡ‚Π΅ΠΈΠ½Π°Π· 2 ΠΈ 9 ассоциированы с ΠΈΠ½ΠΈΡ†ΠΈΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΈ Ρ‚ΡΠΆΠ΅ΡΡ‚ΡŒΡŽ Π₯БН, Ρ€Π°Π·Π²ΠΈΠ²ΡˆΠ΅ΠΉΡΡ послС Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ Ρ€Π°ΠΊΠ° ΠΌΠΎΠ»ΠΎΡ‡Π½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ‹ Π°Π½Ρ‚Ρ€Π°Ρ†ΠΈΠΊΠ»ΠΈΠ½Π°ΠΌΠΈ, Ρ‡Ρ‚ΠΎ ΠΌΠΎΠΆΠ΅Ρ‚ ΡΠΏΠΎΡΠΎΠ±ΡΡ‚Π²ΠΎΠ²Π°Ρ‚ΡŒ Ρ€Π΅ΠΌΠΎΠ΄Π΅Π»ΠΈΡ€ΠΎΠ²Π°Π½ΠΈΡŽ сСрдца ΠΈ ΠΏΡ€ΠΎΠ³Ρ€Π΅ΡΡΠΈΡ€ΠΎΠ²Π°Π½ΠΈΡŽ систоличСской дисфункции. ΠšΠΎΠ½Ρ†Π΅Π½Ρ‚Ρ€Π°Ρ†ΠΈΠΈ матриксных ΠΌΠ΅Ρ‚Π°Π»Π»ΠΎΠΏΡ€ΠΎΡ‚Π΅ΠΈΠ½Π°Π· 2 ΠΈ 9 Π² сывороткС ΠΊΡ€ΠΎΠ²ΠΈ слуТат ΠΏΡ€Π΅Π΄ΠΈΠΊΡ‚ΠΎΡ€Π°ΠΌΠΈ нСблагоприятного тСчСния Π°Π½Ρ‚Ρ€Π°Ρ†ΠΈΠΊΠ»ΠΈΠ½ΠΈΠ½Π΄ΡƒΡ†ΠΈΡ€ΠΎΠ²Π°Π½Π½ΠΎΠΉ сСрдСчной нСдостаточности.ЦСль. ΠžΡ†Π΅Π½ΠΈΡ‚ΡŒ Ρ€ΠΎΠ»ΡŒ матриксных ΠΌΠ΅Ρ‚Π°Π»Π»ΠΎΠΏΡ€ΠΎΡ‚Π΅ΠΈΠ½Π°Π· 2 (ММП-2) ΠΈ 9 (ММП-9) Π² Ρ€Π°Π·Π²ΠΈΡ‚ΠΈΠΈ ΠΈ Ρ‚Π΅Ρ‡Π΅Π½ΠΈΠΈ Π°Π½Ρ‚Ρ€Π°Ρ†ΠΈΠΊΠ»ΠΈΠ½ΠΈΠ½Π΄ΡƒΡ†ΠΈΡ€ΠΎΠ²Π°Π½Π½ΠΎΠΉ хроничСской сСрдСчной нСдостаточности (Π₯БН) Π² Ρ‚Π΅Ρ‡Π΅Π½ΠΈΠ΅ 24 мСс. наблюдСния.ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Ρ‹ ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹. Π’ исслСдованиС Π²ΠΊΠ»ΡŽΡ‡Π΅Π½Ρ‹ 114 ΠΆΠ΅Π½Ρ‰ΠΈΠ½ с Ρ€Π°Π·Π²ΠΈΠ²ΡˆΠ΅ΠΉΡΡ Ρ‡Π΅Ρ€Π΅Π· 12 мСс. послС Π·Π°Π²Π΅Ρ€ΡˆΠ΅Π½ΠΈΡ Ρ…ΠΈΠΌΠΈΠΎΡ‚Π΅Ρ€Π°ΠΏΠΈΠΈ ΠΏΠΎ ΠΏΠΎΠ²ΠΎΠ΄Ρƒ Ρ€Π°ΠΊΠ° ΠΌΠΎΠ»ΠΎΡ‡Π½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ‹ Π₯БН. ΠšΠΎΠ½Ρ‚Ρ€ΠΎΠ»ΡŒΠ½ΡƒΡŽ Π³Ρ€ΡƒΠΏΠΏΡƒ (n = 70) составили ΠΆΠ΅Π½Ρ‰ΠΈΠ½Ρ‹ (срСдний возраст 45,0 [42,0; 50,0] Π»Π΅Ρ‚), ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Π΅ ΠΏΠΎΠ»ΡƒΡ‡Π°Π»ΠΈ доксорубицин, Π½ΠΎ Ρƒ Π½ΠΈΡ… Π½Π΅ Ρ€Π°Π·Π²ΠΈΠ»Π°ΡΡŒ Π₯БН Ρ‡Π΅Ρ€Π΅Π· 12 мСс. послС Ρ…ΠΈΠΌΠΈΠΎΡ‚Π΅Ρ€Π°ΠΏΠΈΠΈ. Π£Ρ€ΠΎΠ²Π½ΠΈ Π±ΠΈΠΎΠΌΠ°Ρ€ΠΊΠ΅Ρ€ΠΎΠ² (ММП-2, ММП-9, ΠΏΡ€Π΅Π΄ΡˆΠ΅ΡΡ‚Π²Π΅Π½Π½ΠΈΠΊΠ° ΠΌΠΎΠ·Π³ΠΎΠ²ΠΎΠ³ΠΎ натрийурСтичСского ΠΏΠ΅ΠΏΡ‚ΠΈΠ΄Π° (NT-proBNP)) Π² сывороткС ΠΊΡ€ΠΎΠ²ΠΈ опрСдСляли с ΠΏΠΎΠΌΠΎΡ‰ΡŒΡŽ сэндвич-ΠΈΠΌΠΌΡƒΠ½ΠΎΠ°Π½Π°Π»ΠΈΠ·Π°.Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹. Π‘ΠΎΠ»ΡŒΠ½Ρ‹Π΅ Π₯БН ΠΈΠΌΠ΅Π»ΠΈ ΠΏΡ€ΠΈΠ·Π½Π°ΠΊΠΈ рСмодСлирования сСрдца ΠΈ Π±ΠΎΠ»Π΅Π΅ высокиС значСния NT-proBNP, MMП-2 ΠΈ MMП-9 (p<0,001), Ρ‡Π΅ΠΌ ΠΆΠ΅Π½Ρ‰ΠΈΠ½Ρ‹ ΠΈΠ· ΠΊΠΎΠ½Ρ‚Ρ€ΠΎΠ»ΡŒΠ½ΠΎΠΉ Π³Ρ€ΡƒΠΏΠΏΡ‹. Π§Π΅Ρ€Π΅Π· 24 мСс. наблюдСния всС ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚Ρ‹ с Π₯БН Ρ€Π°Π·Π΄Π΅Π»Π΅Π½Ρ‹ Π½Π° Π΄Π²Π΅ Π³Ρ€ΡƒΠΏΠΏΡ‹: 1-я Π³Ρ€ΡƒΠΏΠΏΠ° – ΠΆΠ΅Π½Ρ‰ΠΈΠ½Ρ‹ с нСблагоприятным Ρ‚Π΅Ρ‡Π΅Π½ΠΈΠ΅ΠΌ Π₯БН (n = 54), 2-я Π³Ρ€ΡƒΠΏΠΏΠ° – с благоприятным Ρ‚Π΅Ρ‡Π΅Π½ΠΈΠ΅ΠΌ ΠΏΠ°Ρ‚ΠΎΠ»ΠΎΠ³ΠΈΠΈ (n = 60). ΠšΡ€ΠΈΡ‚Π΅Ρ€ΠΈΠΈ нСблагоприятного тСчСния Π₯БН: появлСниС Π½ΠΎΠ²Ρ‹Ρ… ΠΈΠ»ΠΈ ΡƒΡ…ΡƒΠ΄ΡˆΠ΅Π½ΠΈΠ΅ ΠΈΠΌΠ΅ΡŽΡ‰ΠΈΡ…ΡΡ симптомов/ΠΏΡ€ΠΈΠ·Π½Π°ΠΊΠΎΠ² БН ΠΈ/ΠΈΠ»ΠΈ госпитализация вслСдствиС дСкомпСнсации БН; сниТСниС Ρ„Ρ€Π°ΠΊΡ†ΠΈΠΈ выброса Π»Π΅Π²ΠΎΠ³ΠΎ ΠΆΠ΅Π»ΡƒΠ΄ΠΎΡ‡ΠΊΠ° Π±ΠΎΠ»Π΅Π΅ 10% ΠΈΠ»ΠΈ ΡƒΠ²Π΅Π»ΠΈΡ‡Π΅Π½ΠΈΠ΅ Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½ΠΎΠ³ΠΎ класса Π₯БН Π½Π° ΠΎΠ΄ΠΈΠ½ ΠΈΠ»ΠΈ Π±ΠΎΠ»Π΅Π΅. Π˜ΡΡ…ΠΎΠ΄Π½Ρ‹Π΅ эхокардиографичСскиС ΠΏΠ°Ρ€Π°ΠΌΠ΅Ρ‚Ρ€Ρ‹ ΠΈ значСния NT-proBNP Π½Π΅ Ρ€Π°Π·Π»ΠΈΡ‡Π°Π»ΠΈΡΡŒ ΠΌΠ΅ΠΆΠ΄Ρƒ Π³Ρ€ΡƒΠΏΠΏΠ°ΠΌΠΈ. Π£Ρ€ΠΎΠ²Π΅Π½ΡŒ MMП-2 Π±Ρ‹Π» Π²Ρ‹ΡˆΠ΅ Π½Π° 8% (p = 0,017), MMП-9 Π½Π° – 18,4% (p<0,001) Π² Π³Ρ€ΡƒΠΏΠΏΠ΅ 1 Π² сравнСнии с Π³Ρ€ΡƒΠΏΠΏΠΎΠΉ 2. Π’Π°ΠΊΠΆΠ΅ Π² 1-ΠΉ Π³Ρ€ΡƒΠΏΠΏΠ΅ ΡƒΡ€ΠΎΠ²Π΅Π½ΡŒ ММП-2 снизился Ρ‡Π΅Ρ€Π΅Π· 24 мСс. наблюдСния, Π²ΠΎ 2-ΠΉ Π³Ρ€ΡƒΠΏΠΏΠ΅, Π½Π°ΠΏΡ€ΠΎΡ‚ΠΈΠ², увСличился ΠΊ ΠΊΠΎΠ½Ρ†Ρƒ ΠΏΠ΅Ρ€ΠΈΠΎΠ΄Π° наблюдСния. Π£Ρ€ΠΎΠ²Π½ΠΈ ММП-2 β‰₯388,2 ΠΏΠ³/ΠΌΠ» (Ρ‡ΡƒΠ²ΡΡ‚Π²ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΡŒ 46%, ΡΠΏΠ΅Ρ†ΠΈΡ„ΠΈΡ‡Π½ΠΎΡΡ‚ΡŒ 80%, AUΠ‘ = 0,64; p = 0,013) ΠΈ ММП-9 β‰₯21,3 ΠΏΠ³/ΠΌΠ» (Ρ‡ΡƒΠ²ΡΡ‚Π²ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΡŒ 86%, ΡΠΏΠ΅Ρ†ΠΈΡ„ΠΈΡ‡Π½ΠΎΡΡ‚ΡŒ 84,4%, AUΠ‘ = 0,9; Ρ€<0,001) ΠΎΠΏΡ€Π΅Π΄Π΅Π»Π΅Π½Ρ‹ ΠΊΠ°ΠΊ ΠΏΡ€Π΅Π΄ΠΈΠΊΡ‚ΠΎΡ€Ρ‹ нСблагоприятного тСчСния Π₯БН.Π—Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅. Π Π΅ΠΌΠΎΠ΄Π΅Π»ΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠ΅ Π²Π½Π΅ΠΊΠ»Π΅Ρ‚ΠΎΡ‡Π½ΠΎΠ³ΠΎ матрикса ΠΌΠΎΠΆΠ΅Ρ‚ ΠΈΠ³Ρ€Π°Ρ‚ΡŒ Π²Π°ΠΆΠ½ΡƒΡŽ Ρ€ΠΎΠ»ΡŒ Π² ΠΏΠ°Ρ‚ΠΎΠ³Π΅Π½Π΅Π·Π΅ Π₯БН, ΠΈΠ½ΠΈΡ†ΠΈΠΈΡ€ΡƒΠ΅ΠΌΠΎΠΉ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π°ΠΌΠΈ класса Π°Π½Ρ‚Ρ€Π°Ρ†ΠΈΠΊΠ»ΠΈΠ½ΠΎΠ². ΠŸΠΎΠ²Ρ‹ΡˆΠ΅Π½Π½Ρ‹Π΅ ΡƒΡ€ΠΎΠ²Π½ΠΈ MMП-2 ΠΈ MMП-9 Π² сывороткС ΠΊΡ€ΠΎΠ²ΠΈ ассоциированы с нСблагоприятным Ρ‚Π΅Ρ‡Π΅Π½ΠΈΠ΅ΠΌ Π°Π½Ρ‚Ρ€Π°Ρ†ΠΈΠΊΠ»ΠΈΠ½ΠΈΠ½Π΄ΡƒΡ†ΠΈΡ€ΠΎΠ²Π°Π½Π½ΠΎΠΉ Π₯БН ΠΈ ΠΌΠΎΠ³ΡƒΡ‚ Π±Ρ‹Ρ‚ΡŒ Ρ€Π΅ΠΊΠΎΠΌΠ΅Π½Π΄ΠΎΠ²Π°Π½Ρ‹ ΠΏΡ€ΠΈ ΠΎΡ†Π΅Π½ΠΊΠ΅ риска нСблагоприятного ΠΏΡ€ΠΎΠ³Π½ΠΎΠ·Π°

    Wien filter using in exploring on low-energy radioactive nuclei

    No full text
    The possibility of using the Wien filter as a mass separator for the neutron enriched nuclei study is under discussion. The nuclei are produced as a result of sup 2 sup 3 sup 8 U fission within the frame of the 'DRIBs' project. The main ion-optics characteristics of the Wien filter are obtained using the moment method. Parameter optimization has been fulfilled to obtain the maximum resolution. The ion beam dynamics and heavy ion separation have been illustrated using the macroparticle simulation for the chosen optimal filter parameter. It is shown that the resolution can be obtained on the level higher than 10 sup 2. It provides an effective separation of the fission fragments with the high atomic number

    The protecting effect of L-carnitine on Ca(2+)-loaded rat liver mitochondria

    No full text
    It is shown that L-carnitine strongly increases the ability of rat liver mitochondria to respond to the train of Ca2+ additions by a transient stimulation of the State-4 respiration rate. Such an effect requires ATP and the L-carnitine efficiency strongly decreases when ATP is omitted. Oleate influences the mitochondria in a fashion opposite to that of L-carnitine. The oleate effect is strongly diminished by L-carnitine. Again, the L-carnitine effect requires ATP, and D-carnitine fails to substitute for L-carnitine. It is suggested that L-carnitine removes, in an ATP-dependent manner, endogenous or added fatty acids, which are involved in oxidative damage of Ca(2+)-loaded mitochondria

    Interaction of carnitine with mitochondrial cardiolipin

    No full text
    The physiological role of L-carnitine is to determine the transport of acyl-CoA through the mitochondrial membrane. However, some observations may also suggest a direct effect of the molecule per se on the physical properties of the membrane, most probably at the level of the binding site. This possibility has been investigated by studying the influence of adriamycin, a drug that binds to cardiolipin, on the effect of carnitine on isolated rat liver mitochondria. It has been found that adriamycin almost abolishes the activating effect of carnitine on state 2 respiration. The effect and its inhibition is seen by using either the L-form of carnitine or the D-form or both. Cardiolipin removes the effect of adriamycin and restores the activation by carnitine. It is proposed that some effects of carnitine on mitochondrial properties may be the result of interaction of carnitine with cardiolipin at the membrane level
    • …
    corecore